Skip to main content
Jiayin Zheng on Muck Rack

Jiayin Zheng

As seen in: Nature, Wiley Online Library, MDPI, Taylor & Francis Online, ACS Publications, Journal of Foot and Ankle Research, Royal Society of Chemistry, Cell Reports Physical Science
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jiayin

Contact Jiayin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Development and validation of the predictive aplastic score system (PASS): a simplified tool to diagnose acquired aplastic anemia in adults

|
By Gabriel Aleixo, Jiayin Zheng, Jimmy Lee, Eleonore Kaphan, Wei-Ying Jen, Mia Djulbegovic, Jairo Matthews, Tapan M Kadia, Timothy Olson, Regis de Latour, Flore Sicre de Fontbrune, Taha Bat, Courtney DiNardo, Daria V. Babushok, HeeJin Cheon, Stephanie Soewito, Neha Kalakuntla, Sumasri Kotha, Alex Rupsee
| Nature Verified
Abstract Acquired aplastic anemia (AA) can present similarly to inherited bone marrow failure syndromes (IBMFS) but treatment differs. AA diagnosis relies on excluding IBMFS; however, genetic testing is not always available, may delay care or be inconclusive. We developed the Predictive Aplastic Score System (PASS), a clinical tool using readily available data to distinguish AA from IBMFS in adults. The training cohort included 212 adults (162 AA, 50 IBMFS).
Open in Who Shared Issue with article?

Controversial issues in clinical investigation of rare disease drug development

|
By Shein-Chung Chow, Jiayin Zheng
| Taylor & Francis Online
For rare disease drug development, a single-stage hypothesis testing procedure is often considered for clinical investigation regarding safety and efficacy of a test treatment study. Under the hypothesis testing framework, “p-value less than 0.05 with at least 80% power” is often used as the gold standard in the regulatory review/approval process.
Open in Who Shared Issue with article?

Luminescent Cerium(III) Complexes with Poly(mercaptoimidazolyl)borate: A New Emitter Based on S-Coordinating Ligands

|
By Jiayin Zheng, Ruoyao Guo, Hao Qi, Huanyu Liu
| ACS Publications
Open in Who Shared Issue with article?
See all 10 articles